Did State Medicaid Programs Finance Plavix Direct-to-Consumer Advertising?
When the November 15, 2009, AARP Rx Watchdog Report revealed that manufacturer prices for widely used brand name drugs have climbed dramatically over the...
FDA Intern & the Next Steps Toward Pharma Social Media Salvation!
Now that the big FDA public hearing is over, many people are asking "What's the next steps?" If you are like me, you expect...
Is Google the New FDA?
At the recent FDA public hearing, Google presented its "ideas" for standard paid search ads for Rx products. The following, for example, shows its...
Women May Achieve 0.2 More “Satisfying Sexual Events” Per Week with BI’s New “Desire...
Stop the presses! I mean literally stop press coverage of a new drug under development by the family-owned drug company Boehringer Ingelheim GmbH (BI)....
FDA Social Media Guidelines Best Done in Baby Steps
In his closing remarks at yesterday's public hearing on FDA regulation of social media, Tom Abrams, Director of FDA's Division of Drug Marketing, Advertising,...
FDA Social Media Hearing Day 1: My Key Takeaways
In my presentation before the FDA at yesterday's public hearing, I made some specific suggestions, including the use of an FDA-designated hash tag to...
I’m Off to FDA Hearing: Here’s What I Plan to Show (PPTs) and Tell...
I am scheduled to make two presentations at the November 12 - 13 FDA public hearing on the use of social media for Rx...
FDA Panelists at the Upcoming Social Media Public Hearing
Only the following 13 FDA panel members will be able to ask questions during this week's public hearing on the use of social media...
PhRMA Proposes FDA-Approved Use of Universal Safety Symbol
In a telephone news briefing, PhRMA proposed an "FDA-Approved Use of Universal Safety Symbol" that could be used in branded/sponsored ad links (eg,...
FDA Public Hearing: Not Deja Vu All Over Again?
At eyeforpharma's eCommunication & Online Marketing Summit, the audience had a lot of questions about the upcoming FDA public hearing. At one point,...
